Daniel Johnson
Family · Lebanon, MONPI 1124199690
Payments from drug & device makers
Across 113 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$223
- Amgen$181
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$162
- Lilly USA, LLC$160
- Merck$155
- Abbott$151
- plus $847 from 21 others
What the payments were for
- Food & beverage$1,879100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $223 |
| Amgen | 12 | $181 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $162 |
| Lilly USA, LLC | 10 | $160 |
| Merck | 10 | $155 |
| Abbott | 7 | $151 |
| AstraZeneca | 8 | $136 |
| Novartis | 7 | $97 |
| AbbVie | 6 | $93 |
| Pfizer | 4 | $61 |
| Bayer | 4 | $60 |
| Dexcom, Inc. | 3 | $55 |
| Boehringer Ingelheim | 3 | $51 |
| GSK | 3 | $45 |
| Acadia Pharmaceuticals Inc | 2 | $35 |
| Johnson & Johnson | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 2 | $25 |
| Radius Health, Inc. | 1 | $24 |
| Exact Sciences | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Edwards Lifesciences | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$1,879 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 151 | $141,499 |
| OzempicSemaglutide | 88 | $89,105 |
| JardianceEmpagliflozin | 90 | $66,216 |
| TrulicityDulaglutide | 24 | $43,907 |
| MounjaroTirzepatide | 37 | $38,635 |
| XareltoRivaroxaban | 48 | $28,857 |
| Repatha SureclickEvolocumab | 35 | $19,214 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 36 | $19,076 |
| Nurtec OdtRimegepant Sulfate | 12 | $18,777 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $18,524 |
| FarxigaDapagliflozin Propanediol | 15 | $17,633 |
| EntrestoSacubitril/Valsartan | 14 | $15,946 |
| SymbicortBudesonide/Formoterol Fumarate | 44 | $14,803 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $13,595 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $13,088 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Nurtec Odt, Abrysvo | $61 | $163,672175 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat | $51 | $96,833137 claims |
| Novo NordiskOzempic | $223 | $89,10588 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $160 | $82,54361 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $136 | $50,96083 claims |
| Johnson & JohnsonXarelto | $28 | $28,85748 claims |
| GSKAnoro Ellipta, Breo Ellipta | $45 | $21,26040 claims |
| NovartisEntresto | $97 | $15,94614 claims |
| AbbVieSynthroid | $93 | $1,80120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.
Other family in Lebanon
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.